https://www.merck.com › media › news
6 дн. назад · The company assumes no duty to update the information to reflect subsequent developments. Readers of …
https://www.merck.com › news › mercks-tulisokibart-met-primary-and-key-secondary-endpoints...
22 июн. 2026 г. · Results from the ATLAS-UC Study 2 will be presented with the results from the ongoing induction and …
https://www.marketbeat.com › stocks › NYSE › MRK › fda-events
3 дн. назад · Merck reported positive topline results from the Phase 3 ATLAS-UC induction-only study of tulisokibart (MK …
https://www.msd.com › wp-content › uploads › sites › Tulisokibart-Clinical-Trial...
MSD is conducting multiple pivotal Phase 3 clinical trials to evaluate the efficacy and safety of tulisokibart in patients with the …
https://www.msd.com › news › msds-tulisokibart-met-primary-and-key-secondary-endpoints-in...
22 июн. 2026 г. · Results from the ATLAS-UC Study 2 will be presented with the results from the ongoing induction and …
